Publications by authors named "Vedat B Erol"
During the coronavirus disease 2019 pandemic, global approach was to isolate populations with quarantine procedures to reduce the spread of this deadly virus until effective treatments are found or vaccines are developed. mRNA-based vaccines became available in the United States in March 2020. The Food and Drug Administration even issued an Emergency Use Authorization for individuals 16 years and older in December 2020.
View Article and Find Full Text PDFArticle Synopsis
- The study looked at how certain immune cells in breast cancer patients change before and after chemotherapy and how these changes relate to their survival.
- Researchers found that the levels of these immune cells decreased after treatment, but higher levels before treatment were linked to better outcomes.
- The results suggest that measuring these immune cells can help doctors predict which patients might have better chances of surviving after treatment.
Background: We aimed to compare the level of hepatic FIB-4 scores between COVID-19 patients who had pneumonia and COVID-19 patients who had no pneumonia in an attempt to develop a risk assessment after the treatment and recovery of active COVID-19 infection.
Methods: The study included 80 patients who were consecutively selected and admitted to an internal medicine outpatient clinic for a control examination after COVID-19 infection. Chest tomography was performed on all patients during the COVID-19 infection.